Financial statements Plus Solinea Pharma
Balance sheet data of PLUS SOLINEA PHARMA
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 104 593,70 | 104 172,52 | 191 698,00 | 487 855,29 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
B. Current assets | 104 593,70 | 104 172,52 | 191 698,00 | 487 855,29 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - |
D. Own shares (stocks) | 0,00 | 0,00 | - | - |
Total liabilities | 104 593,70 | 104 172,52 | 191 698,00 | 487 855,29 |
A. Equity | -159 852,43 | -143 868,40 | -234 483,45 | -189 629,93 |
B. Liabilities and provisions for liabilities | 264 446,13 | 248 040,92 | 426 181,45 | 677 485,22 |
I. Long-term liabilities | 118 017,60 | 0,00 | - | - |
II. Short-term liabilities | 146 428,53 | 248 040,92 | 389 781,45 | 644 385,22 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.